IBB vs MUB

iShares Biotechnology ETF vs iShares National Muni Bond ETF

Quick take
  • MUB has the lower expense ratio at 0.05% vs 0.44% for IBB.
  • MUB pays a higher dividend yield (3.16%).

Side-by-side metrics

MetricIBBMUB
Expense ratio
Annual fee. Lower is better.
0.44%0.05%
Dividend yield
Trailing 12-month yield.
0.22%3.16%
AUM
Assets under management — bigger funds are typically more liquid.
$9.09B$45.82B
YTD return
16.44%1.42%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.690.90
P/E ratio
24.89
Last price
$197.34$106.94
Inception
Issuer
iSharesiShares

IBB top holdings

Top holdings · IBB
VRTXVertex Pharmaceuticals Inc8.07%
AMGNAmgen Inc7.82%
GILDGilead Sciences Inc6.83%
REGNRegeneron Pharmaceuticals Inc4.90%
ARGXargenx SE ADR3.75%
ALNYAlnylam Pharmaceuticals Inc3.12%
NTRANatera Inc2.89%
RVMDRevolution Medicines Inc Ordinary Shares2.78%
BIIBBiogen Inc2.46%
ILMNIllumina Inc2.07%
Sector breakdown · IBB
Healthcare100.0%

MUB top holdings

Top holdings · MUB
MCSXXBlackRock Liquidity MuniCash Instl0.26%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About MUB

MUB (iShares National Muni Bond ETF) is US municipal (tax-exempt) bonds. Managed by iShares, the fund carries $45.8B in assets under management, an expense ratio of 0.05%, a dividend yield of 3.16%. Its largest holding is BlackRock Liquidity MuniCash Instl (MCSXX), which represents 0.3% of the portfolio.